RESUMO
Chemsex, a specific form of sexualized drug use (SDU), has rapidly increased in the last decade. This phenomenon could result in a complex public health issue because of the heterogeneity amongst socio-psychological profiles of the practitioners, leading to the difficulty to target specific populations. Healthcare professionals need to be aware of this practice and its related risks to provide care adapted to the individual who consults. Here, we suggest that better knowledge of this field can help to improve prevention measures and provide information with a non-judgmental and respectful approach to those who practice chemsex. Bolmont M, Tshikung ON, Trellu LT. Chemsex, a Contemporary Challenge for Public Health. J Sex Med 2022;19:1210-1213.
Assuntos
Minorias Sexuais e de Gênero , Transtornos Relacionados ao Uso de Substâncias , Homossexualidade Masculina/psicologia , Humanos , Masculino , Saúde Pública , Comportamento SexualRESUMO
In 2015, the publication of important studies allowed the development of new guidelines, notably by WHO and the European AIDS ClinicalSociety (EACS), for HIV preventive treatment (pre-exposure prophylaxis), as well as for the start of antiretroviral treatment. The START and TEMPRANO studies have extended the treatment to all HIV-infected patients, irrespective of the level of immunosuppression and therefore the CD4 count. In addition, innovative screening methods, such as self-tests, are now available in all French pharmacies since 15 September 2015. The latest developments in 2015 concerning the prevention, screening, and treatment of HIV are discussed in this article and will certainly have an impact on the care of patients in Switzerland.
